Kelliher MA - Search Results

1

TBK1 inhibition unleashes RIPK1, resensitizing tumors to immunotherapy.

Kelliher MA, Fitzgerald KA. Kelliher MA, et al. Trends Immunol. 2023 Mar;44(3):156-158. doi: 10.1016/j.it.2023.01.009. Epub 2023 Feb 4. Trends Immunol. 2023. PMID: 36740513

2

RIP1 links inflammatory and growth factor signaling pathways by regulating expression of the EGFR.

Ramnarain DB, Paulmurugan R, Park S, Mickey BE, Asaithamby A, Saha D, Kelliher MA, Mukhopadhyay P, Banani F, Madden CJ, Wright PS, Chakravarty S, Habib AA. Ramnarain DB, et al. Among authors: kelliher ma. Cell Death Differ. 2008 Feb;15(2):344-53. doi: 10.1038/sj.cdd.4402268. Epub 2007 Nov 16. Cell Death Differ. 2008. PMID: 18007664

3

The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IkappaB kinase and c-Jun N-terminal kinase.

Lin Y, Devin A, Cook A, Keane MM, Kelliher M, Lipkowitz S, Liu ZG. Lin Y, et al. Mol Cell Biol. 2000 Sep;20(18):6638-45. doi: 10.1128/MCB.20.18.6638-6645.2000. Mol Cell Biol. 2000. PMID: 10958661 Free PMC article.

4

ABL oncogenes directly stimulate two distinct target cells in bone marrow from 5-fluorouracil-treated mice.

Kelliher MA, Weckstein DJ, Knott AG, Wortis HH, Rosenberg N. Kelliher MA, et al. Oncogene. 1993 May;8(5):1249-56. Oncogene. 1993. PMID: 8479746

5

NFKB1 is a direct target of the TAL1 oncoprotein in human T leukemia cells.

Chang PY, Draheim K, Kelliher MA, Miyamoto S. Chang PY, et al. Among authors: kelliher ma. Cancer Res. 2006 Jun 15;66(12):6008-13. doi: 10.1158/0008-5472.CAN-06-0194. Cancer Res. 2006. PMID: 16778171

6

NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2.

Yang Y, Yin C, Pandey A, Abbott D, Sassetti C, Kelliher MA. Yang Y, et al. Among authors: kelliher ma. J Biol Chem. 2007 Dec 14;282(50):36223-9. doi: 10.1074/jbc.M703079200. Epub 2007 Oct 18. J Biol Chem. 2007. PMID: 17947236 Free article.

7

Tpl2/cot signals activate ERK, JNK, and NF-kappaB in a cell-type and stimulus-specific manner.

Das S, Cho J, Lambertz I, Kelliher MA, Eliopoulos AG, Du K, Tsichlis PN. Das S, et al. Among authors: kelliher ma. J Biol Chem. 2005 Jun 24;280(25):23748-57. doi: 10.1074/jbc.M412837200. Epub 2005 Apr 15. J Biol Chem. 2005. PMID: 15833743 Free article.

8

Aging, calorie restriction and ubiquitin-dependent proteolysis in the livers of Emory mice.

Scrofano MM, Shang F, Nowell TR Jr, Gong X, Smith DE, Kelliher M, Dunning J, Mura CV, Taylor A. Scrofano MM, et al. Mech Ageing Dev. 1998 Apr 1;101(3):277-96. doi: 10.1016/s0047-6374(97)00178-4. Mech Ageing Dev. 1998. PMID: 9622231

9

Therapeutic targeting of the cyclin D3:CDK4/6 complex in T cell leukemia.

Sawai CM, Freund J, Oh P, Ndiaye-Lobry D, Bretz JC, Strikoudis A, Genesca L, Trimarchi T, Kelliher MA, Clark M, Soulier J, Chen-Kiang S, Aifantis I. Sawai CM, et al. Among authors: kelliher ma. Cancer Cell. 2012 Oct 16;22(4):452-65. doi: 10.1016/j.ccr.2012.09.016. Cancer Cell. 2012. PMID: 23079656 Free PMC article.

10

Differences in oncogenic potency but not target cell specificity distinguish the two forms of the BCR/ABL oncogene.

Kelliher M, Knott A, McLaughlin J, Witte ON, Rosenberg N. Kelliher M, et al. Mol Cell Biol. 1991 Sep;11(9):4710-6. doi: 10.1128/mcb.11.9.4710-4716.1991. Mol Cell Biol. 1991. PMID: 1875948 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

95 results

Search Page